131 related articles for article (PubMed ID: 36697389)
21. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
[TBL] [Abstract][Full Text] [Related]
22. Female sexuality and vaginal health across the menopausal age.
Cagnacci A; Venier M; Xholli A; Paglietti C; Caruso S;
Menopause; 2020 Jan; 27(1):14-19. PubMed ID: 31738734
[TBL] [Abstract][Full Text] [Related]
23. Use of Growth Factors for Vulvo/Vaginal Bio-Stimulation.
Isaza PG
Surg Technol Int; 2019 May; 34():269-273. PubMed ID: 30388724
[TBL] [Abstract][Full Text] [Related]
24. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
Rahn DD; Richter HE; Sung VW; Hynan LS; Pruszynski JE
Am J Obstet Gynecol; 2023 Sep; 229(3):309.e1-309.e10. PubMed ID: 37244454
[TBL] [Abstract][Full Text] [Related]
25. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
Stute P
Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
[TBL] [Abstract][Full Text] [Related]
26. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
[TBL] [Abstract][Full Text] [Related]
27. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Hocké C; Diaz M; Bernard V; Frantz S; Lambert M; Mathieu C; Grellety-Cherbero M
Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926
[TBL] [Abstract][Full Text] [Related]
28. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
[TBL] [Abstract][Full Text] [Related]
29. Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors.
Siliquini GP; Bounous VE; Novara L; Giorgi M; Bert F; Biglia N
Breast J; 2021 May; 27(5):448-455. PubMed ID: 33728801
[TBL] [Abstract][Full Text] [Related]
30. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial.
Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y
Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
32. Vaginal CO
Jacobsen S; Glavind-Kristensen M; Jensen AB; Forman A; Bor P
BMC Cancer; 2023 Nov; 23(1):1164. PubMed ID: 38031020
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women.
Nappi RE; Kotek M; Brešt'anský A; Giordan N; Tramentozzi E
Climacteric; 2020 Oct; 23(5):519-524. PubMed ID: 32396754
[No Abstract] [Full Text] [Related]
34. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
Sinha A; Ewies AA
Climacteric; 2013 Jun; 16(3):305-12. PubMed ID: 23215675
[TBL] [Abstract][Full Text] [Related]
35. An effective non-hormonal option with high tolerability for mild to moderate symptoms of vaginal dryness associated with menopause.
Eichler S; Panz M; Harder A; Masur C; Häuser M; Wiesche ESZ
Maturitas; 2024 Jul; 185():107978. PubMed ID: 38583316
[TBL] [Abstract][Full Text] [Related]
36. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
[TBL] [Abstract][Full Text] [Related]
37. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
Gambacciani M; Levancini M
Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
[TBL] [Abstract][Full Text] [Related]
38. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study.
Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; Giuliano M; Lauria R; De Santo I; Conforti A; Gallo A; Nazzaro G; De Placido S; Locci M; De Placido G
Menopause; 2018 Jun; 25(6):657-662. PubMed ID: 29286986
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
[TBL] [Abstract][Full Text] [Related]
40. Effect of oestriol gel on dyspareunia in postmenopausal women in 2 weeks of treatment: a pilot study.
Cuerva MJ; González SP; Lazaro-Carrasco De La Fuente J; Lopez FJ; Nieto C
J Obstet Gynaecol; 2022 Oct; 42(7):3397-3399. PubMed ID: 35658728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
